Advertisement

Topics

Latest "Barcelona Spine Center" News Stories

21:58 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Barcelona Spine Center" found in our extensive news archives from over 250 global news sources.

More Information about Barcelona Spine Center on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Barcelona Spine Center for you to read. Along with our medical data and news we also list Barcelona Spine Center Clinical Trials, which are updated daily. BioPortfolio also has a large database of Barcelona Spine Center Companies for you to search.

Showing "Barcelona Spine Center" News Articles 1–25 of 5,600+

Monday 25th March 2019

HitGen Forms Dermatology Lead Discovery Partnership with Spain's Almirall

HitGen of Chengdu will collaborate with Almirall. a Barcelona dermatology company, to identify novel small molecule leads for targets of interest. HitGen will search its DNA-encoded library technology platform, which is currently estimated to contain 400 billion leads, to discover, synthesize and screen the leads. Almirall asked HitGen to discover leads for new targets associated with atopic derma...


At AIPAC Policy Conference, Israel’s Sheba Medical Center Recognized as Global Leaders in Healthcare Innovation

Israel’s Sheba Medical Center and Dr. Nathalie Bloch were recognized on Sunday at AIPAC’s annual policy conference in Washington, DC. for bringing pioneering medical advancements to the Middle East and the World. On the heels of Sheba Medical Center being named one of “The Top 10 Hospitals in the World,” Dr. Bloch spoke about Israel’s role as a medical powerhouse across the globe. WASHIN...

Say Good Bye to Meniere’s Disease—Here’s How to Make Your World Stop Spinning

Based on 1,000 one-week intensive care patients at Burcon Chiropractic Meniere's Research Institute, 97% reported dramatic improvement or elimination of vertigo after one year follow up. GRAND RAPIDS, Mich. (PRWEB) March 25, 2019 Please join twenty thousand Meniere’s patients that have been helped since the Journal of Upper Cervical Chiropractic Research published "Health Outcomes Foll...


Tredegar Personal Care Exhibiting at IDEA Show in Miami

Tredegar Personal Care, a leading supplier to the disposable absorbent hygiene industry, is showcasing its newest products for the baby, feminine and adult care markets at the IDEA Show in Miami, FL. Tredegar Personal Care joins about 7,000 exhibitors at the Miami Beach Convention Center from March 25 to March 28. Among the innovations that Tredeg...

Ciming Boao International Hospital Fertility Center Begins First Trial Operations

BOAO, China, March 25, 2019 /PRNewswire/ -- Ciming Boao International Hospital and Fertility Center, a state-of-the-art 5,000sq meter facility has begun trial operations. Built on 16.5 acres of land located within the "Boao Lecheng Medical Tourism Pilot Zone," the hospital has received the support of the National Health Commission's Women and Children Department and will offer standard f...

Arcis Golf Partners with Els For Autism - New Programs Include Fundraising and Awareness Nationwide

Arcis Golf —the second largest owner-operator of private, resort, and daily fee clubs in the United States—will launch a nationwide campaign in April called “Arcis Round Up For Autism” that expands its partnership with legendary golfer Ernie Els and the Els for Autism Foundation. DALLAS (PRWEB) March 25, 2019 Arcis Golf —the second largest owner-operator of private, resort, and daily fe...

Physicians’ Education Resource® Presents “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know”

This live symposium will be held adjunct to the 2019 American College of Physicians Internal Medicine Meeting Physicians’ Education Resource® (PER®), a worldwide leader in continuing medical education (CME), will conduct a live CME-accredited activity, “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know,” as a satelli...

Netsmart Implements Industry-First Interoperability 360X Standards to Support Transparency Between Healthcare Providers

Netsmart has announced plans to release industry-first interoperability standards to improve communication between primary care and community-based healthcare providers. The new standards are designed to improve referral management, close communication gaps and enable transparency between care settings. The healthcare IT

Historic Partnership between the Weizmann Institute of Science and Institut Curie

On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically -...

Cancer Treatment Centers of America Set to Open Third Outpatient Care Center in Phoenix Area

Joining North Phoenix and Scottsdale locations, the Gilbert Outpatient Care Center will offer advanced oncology treatment in an outpatient setting Cancer Treatment Centers of America® (CTCA), located in Goodyear, Ariz., is again expanding its Valley network with the opening of its third Outpatient Care Center in Gilbert. This third location will expan...

How one family’s letter prompted the creation of a new telehealth program

After Jared and Kristina Burns went through a harrowing experience with their child, they wrote a letter to Walla Walla, Washington-based Providence St. Mary Medical Center, requesting t

CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board

SHANGHAI, March 25, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) is pleased to announce the appointment of three internationally renowned oncologists Paul A. Bunn, Jr., MD, Elizabeth M. Jaffee, MD, and Richard S. Finn, MD, as the company's Scientific Advisory Board (SAB) members. With their deep scientific and medical expertise as well as extensive leadership and ad...

CIRCULOGENE’s Precision Genomic Profiling Technology Featured in Three AACR 2019 Abstracts

Posters present data on utility of cfDNA for patient mutation load in NSCLC; cfRNA PD-L1 + MSI single-blood-tube testing; and innovative salvage of buccal NGS testing CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, will be presenting three abstracts at the 2019

Nexus Recovery Services Announces the Release of How-to Support Someone in Addiction Recovery

Nexus Recovery Services has published a comprehensive infographic entitled “How-to Support Someone in Addiction Recovery” to inform people on ways to support a friend or loved one on their journey of recovery from substance abuse and addiction. LOS ANGELES (PRWEB) March 25, 2019 Nexus Recovery Services has published a comprehensive infographic entitled “How-to Support Someone in Addiction R...

To Advance Collaboration in Precision Medicine, Bio-IT World Opens Global Event to the Public April 16-18, 2019

Through April 5, Register for Complimentary Exhibit Hall & Keynote Pass to Boston Conference & Expo In the spirit of open collaboration, the world’s premier bio-IT conference is inviting the community to experience and contribute to the future of precision medicine—together. With a focus on AI, data science and other “data-driven...

Bean dreams: Entrepreneur hopes Coffee Rehab will put recovery front and center

The coffee shop Katy Armendariz envisions would support recovery from all angles. Staff and managers would all be in active recovery, so everyone would feel comfortable talking about their lives and support each other in their struggles to stay sober.

Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting

SYDNEY, March 25, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) has been selected to present data from the Phase I study of Cantrixil in ovarian cancer at the American Association for Cancer Research (AACR) 2019 Annual Meeting. AACR's Annual Meeting is one of the top-tier academic conferences worldwide and b...

ImpediMed Announces PREVENT Trial Accepted for Publication and Presentation at the 2019 Annual Meeting of the American Society of Breast Surgeons

Largest prospective, multi-center, randomized trial undertaken in the prevention of breast cancer-related lymphedema ImpediMed Limited (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), today announces that the pre-specified, ...

Bone Biologics Receives Human Research Ethics Committee (HREC) Approval for the First Center of a Multicenter Pilot Clinical Trial to Evaluate NB1 (NELL-1/DBX®) in Australia

Bone Biologics Corp. (OTCQB:BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, today has announced that it received Human Research Ethics Committee (HREC) approval on March 20, 2019, for the first center of a multicenter pilot clinical trial to evaluate NB1 (NELL-1/DBX®) in 30 patients in Australia. The ...

F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting

Three poster presentations highlighting the synergistic benefits of the tetravalent bispecific (mAb2™) format compared to monospecific agents either alone or in combination F-star, a clinical-stage biopharmaceutical company pioneering the development of novel tetravalent bispecific antibodies that target the immune system to fight...

H3 Biomedicine Announces Multiple Presentations at Upcoming AACR Annual Meeting

--Presentations highlight company’s expertise seamlessly integrating human biology, data science and modern chemistry to advance a pipeline of investigational breakthrough precision oncology medicines-- H3 Biomedicine Inc., a U.S.-based precision medicine research & development subsidiary of Eisai Co., Ltd., today announced multiple presentations...

Sources of Patients' Expectations of Lumbar Surgery

Where do patients obtain expectations of lumbar surgery outcomes? What can surgeons do to ensure these expectations are appropriate? Spine

TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the Endocrine Society 2019 Annual Meeting

Four Posters Will Present BIJUVA Phase 3 REPLENISH Data About Improvements in Hot Flushes, Night Sweats, Sweating, Quality of Sleep, and Incidence of Vaginal Bleeding in Postmenopausal Women One Oral Presentation and One Poster Will Present ANNOVERA Phase 3 Data About Antiovulatory Effects and Impact on Lipids and Hepatic Proteins ...

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO

NEW ORLEANS, March 25, 2019 /PRNewswire/ -- Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia® (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA1c reductions at 26 weeks was not confirmed. Presented today at the Endocrine Society Annual Meeting in New Orleans, Louisiana, with simultaneous publication ...

Fuse Medical Reports Full Year 2018 Financial Results with Record Earnings

Fuse Medical, Inc., (OTCPINK: FZMD), an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018. Fuse filed its annual report on Form 10-K with the Securities and Exchange Commission on Thursday, March 21, 2019. 2018 Financial Highlight...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks